The pathogenetic role of IL-1β in severe epidermolysis bullosa simplex

J Invest Dermatol. 2013 Jul;133(7):1901-3. doi: 10.1038/jid.2013.31. Epub 2013 Jan 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Anthraquinones / pharmacology
  • Anti-Inflammatory Agents / pharmacology
  • Antibodies / pharmacology
  • Cells, Cultured
  • Epidermolysis Bullosa Simplex / etiology*
  • Epidermolysis Bullosa Simplex / pathology
  • Epidermolysis Bullosa Simplex / physiopathology*
  • Humans
  • Interleukin-1beta / antagonists & inhibitors
  • Interleukin-1beta / drug effects
  • Interleukin-1beta / physiology*
  • Keratin-14 / genetics
  • Keratin-14 / metabolism
  • Keratinocytes / metabolism
  • Keratinocytes / pathology
  • MAP Kinase Signaling System / physiology*
  • Mutation / genetics
  • Severity of Illness Index*
  • Signal Transduction / physiology*

Substances

  • Anthraquinones
  • Anti-Inflammatory Agents
  • Antibodies
  • Interleukin-1beta
  • Keratin-14
  • diacerein